Targeted RNA-sequencing for the evaluation of gene fusions in lung tumors: current status and future prospects

Routinely, patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) are screened for mutations and fusions to direct therapy decision. The majority of molecular laboratories ...